GTM strategy and positioning for healthtech.
Healthtech sells into complex, risk-averse buyers. We sharpen positioning that satisfies clinical, procurement and IT stakeholders, pick the segments worth winning, and build a compliant go-to-market plan.
Where this usually goes wrong.
Your buyer is a committee of clinicians, procurement and IT, each with different concerns. Generic healthtech messaging satisfies none of them, and deals stall in evaluation for months.
What changes when we work together.
- Positioning that satisfies clinical, procurement and IT
- Priority segments ranked by fit and sales cycle
- Evidence and proof mapped to each stakeholder
- A 90-day plan built for complex healthcare buying
The approach, in plain terms.
Stakeholder mapping
We map every stakeholder in a healthtech deal and build messaging each one can say yes to.
Evidence-led positioning
Positioning that leads with clinical evidence, outcomes and integration, because that is what de-risks the decision.
Segment prioritisation
We rank target segments by regulatory fit, procurement route and cycle length.
90-day plan
A plan that respects long, committee-led healthcare cycles, with a clear pipeline reporting line.